ArticleBMC microbiology2026
Isolation and characterization of a bacteriophage targeting Proteus mirabilis for use in culture media.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proteus mirabilis is an important opportunistic bacterium that affects both animal and human health. One of the key characteristics of this bacterium is its distinctive zonal spreading on solid media. This movement, known as swarming, complicates the isolation and identification of pathogenic agents present alongside P. mirabilis in clinical samples. The aim of this study was to isolate a lytic bacteriophage targeting P. mirabilis to prevent its growth and evaluate the use of these phages in cultures of clinical samples contaminated with Proteus. A phage designated as P5663 was isolated using general phage isolation and purification methods. Genomic and electron microscopic analyses suggested that the phage belongs to the class Caudoviricetes, and genome-based comparisons supported its close relatedness to bacteriophages within the family Casjensviridae. The isolated phage was analyzed for its lytic activity against 16 P. mirabilis, one P. vulgaris, and 19 different non-Proteus bacterial species. The growth of P. mirabilis on Tryptic Soy Agar (TSA) medium prepared with the isolated phage was evaluated. All Proteus isolates analyzed in the study were lysed by P5663 Φ, while the other bacterial species were not affected. It was observed that while P. mirabilis suspensions of varying concentrations exhibited growth in the inoculation area on TSA containing P5663 Φ, the zonal spreading (swarming) was inhibited. In conclusion, this study presents a novel perspective on the use of bacteriophages, which have a wide range of applications. It was concluded that phages could be used to inhibit the swarming behavior of P. mirabilis in culture media without affecting the growth of non-target bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.